Glucagon-like peptide 2 is an endogenous mediator of postresection intestinal adaptation.

BACKGROUND After massive small bowel resection, the remnant intestine undergoes compensatory adaptation. We tested the hypothesis that glucagon-like peptide-2 (GLP-2) is an endogenous mediator of postresection intestinal adaptation. METHODS Rats were allocated to 1 of 4 groups: groups 1 and 2 rats underwent mid-small bowel transection and reanastomosis; groups 3 and 4 rats underwent 75% mid-small bowel resection and reanastomosis. Groups 2 and 4 rats were administered 1.8 mg of antirat GLP-2 antibody twice daily beginning immediately after the surgical procedure; groups 1 and 3 rats were administered rabbit serum (control). Ileal specimens were harvested on postoperative day 7. RESULTS Ileal mucosa from group 3 animals displayed morphologic and proliferative indices of adaptation. Each of these indices of adaptation was inhibited by GLP-2 immunoneutralization (group 4). Morphologic and proliferative parameters in the ileum from animals that had undergone transection with reanastomosis were unaffected by GLP-2 immunoneutralization. CONCLUSIONS These results suggest that GLP-2 is an endogenous mediator of postresection intestinal adaptation.

[1]  S. Bloom,et al.  Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth , 1996, Digestive Diseases and Sciences.

[2]  S. Ashley,et al.  Glucagon-like peptide-2: divergent signaling pathways. , 2004, The Journal of surgical research.

[3]  L. Wallace,et al.  Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[4]  S. Ashley,et al.  Glucagon-Like Peptide 2 Stimulates Intestinal Epithelial Proliferation In Vitro , 2002, Digestive Diseases and Sciences.

[5]  S. Ashley,et al.  Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[6]  S. Ashley,et al.  Glucagon-like peptide 2 enhances intestinal epithelial restitution. , 2002, The Journal of surgical research.

[7]  E. Whang,et al.  Understanding and augmenting human intestinal adaptation: a call for more clinical research. , 2002, JPEN. Journal of parenteral and enteral nutrition.

[8]  J. Holst,et al.  Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats , 2002, Regulatory Peptides.

[9]  D. Drucker.  Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.

[10]  Seifert,et al.  Glucagonlike peptide 2 (glp-2) promotes intestinal recovery following chemotherapy-induced enteritis. , 2000, Current surgery.

[11]  J. Holst,et al.  Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon , 2000, Gut.

[12]  S. Ashley,et al.  Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. , 2000, The Journal of surgical research.

[13]  S. Ashley,et al.  Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation. , 2000, The Journal of surgical research.

[14]  J. Vanderhoof,et al.  Short-bowel syndrome in children and adults. , 1997, Gastroenterology.

[15]  D. Drucker,et al.  Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. , 1997, The American journal of physiology.

[16]  D. Drucker,et al.  Induction of intestinal epithelial proliferation by glucagon-like peptide 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Ashley,et al.  Adaptation of the Na+/glucose cotransporter following intestinal resection. , 1994, The Journal of surgical research.

[18]  J. Molenaar,et al.  Short bowel syndrome: Metabolic and surgical management , 1994, The British journal of surgery.

[19]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[20]  E. Weckesser,et al.  Extensive resection of the small intestine. , 1949, American journal of surgery.

[21]  N. Senn.  An Experimental Contribution to Intestinal Surgery with Special Reference to the Treatment of Intestinal Obstruction. , 1887, Annals of surgery.